New Reporting Channels for Adverse Reaction Reports From Healthcare Professionals
9. Dezember 2020 – From 1 January 2021 the adverse drug reaction reports (ADR) are to be sent directly to Swissmedic and not to one of the six Regional Pharmacovigilance Centres.
For further information, see here.